Alvis-Guzman N, Alvis-Zakzuk J, Paz-Wilches J, Fernandez-Mercado J C, de la Hoz-Restrepo F
Grupo de Investigación en Economía de la Salud, Universidad de Cartagena, Cartagena, Colombia.
Grupo de Investigación en Gestion Hospitalaria y Políticas de Salud, Universidad de la Costa-CUC, Barranquilla, Colombia.
Vacunas. 2022 May;23:S41-S45. doi: 10.1016/j.vacun.2021.07.005. Epub 2021 Aug 4.
Colombia designed and adopted a vaccination plan against COVID-19 that will immunize 35 million people. The aim study was to know the willingness to accept the vaccination against COVID-19.
A telephone survey of 11,721 people aged 80 and over, affiliated with a health insurer, was carried. The respondents were the affiliates or their relatives or caregivers.
The average age was 85.0 years (SD: 4.5), with no differences between sexes; 3,344 (28.5%) referred a previous diagnostic test for COVID-19 and 73 were positive for an incidence of 622.8 per 100,000 people (95%CI: 491-778). Regarding the attitude with the vaccination against SARS-CoV-2, 1/4 respondents refrained from giving an opinion or was neutral. When the respondent was a relative, the acceptance of the vaccine was 60.4% (95% CI: 59.5-61.3) with differences by gender: men 62.2% (95% CI: 60.8-63.6) and women of 59.2 (95% CI: 58.0-60.3), < 0.05. When the respondent was the potential recipient of the vaccine, the acceptance of the vaccine was 61.7% (95% CI: 59.4-64.0) and also differed by gender: 70.2% in men (95% CI: 66, 9-73.5) and 55.1% in women (95% CI: 52.0-58.3), < 0.05.
The relatively low acceptance of vaccination against COVID-19 in Colombia poses significant challenges to achieve herd immunity that allows control of the pandemic.
哥伦比亚设计并采用了一项针对新冠病毒的疫苗接种计划，该计划将为3500万人接种疫苗。本研究旨在了解人们接受新冠病毒疫苗接种的意愿。
对11721名80岁及以上加入健康保险公司的人群进行了电话调查。受访者为参保人本人、其亲属或护理人员。
平均年龄为85.0岁（标准差：4.5），男女之间无差异；3344人（28.5%）曾接受过新冠病毒诊断检测，其中73人呈阳性，发病率为每10万人622.8例（95%置信区间：491 - 778）。关于对新冠病毒疫苗接种的态度，四分之一的受访者未发表意见或持中立态度。当受访者为亲属时，疫苗接种接受率为60.4%（95%置信区间：59.5 - 61.3），存在性别差异：男性为62.2%（95%置信区间：60.8 - 63.6），女性为59.2%（95%置信区间：58.0 - 60.3），P<0.05。当受访者为疫苗潜在接种对象时，疫苗接种接受率为61.7%（95%置信区间：59.4 - 64.0），也存在性别差异：男性为70.2%（95%置信区间：66.9 - 73.5），女性为55.1%（95%置信区间：52.0 - 58.3），P<0.05。
哥伦比亚对新冠病毒疫苗接种的接受率相对较低，这对实现群体免疫以控制疫情构成了重大挑战。
